title: Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
authors: Masami
authors: M
authors: Tanaka
authors: Kwiyoung
authors: K
authors: Park
authors: Keiko
authors: K
authors: Tanaka
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008231:Lymphopenia / Q000139:chemically induced*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000097:blood / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced*; D011409:Propylene Glycols / Q000008:administration & dosage* / Q000009:adverse effects; D013110:Sphingosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine